In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
MedPage Today on MSN
First Drug for Deadly Transplant Complication Gets FDA's Blessing
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
Zacks Investment Research on MSN
Omeros gets FDA approval for YARTEMLEA as first therapy for TA-TMA
Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem ...
Techno-Science.net on MSN
Effective diabetes medications to fight cancer
Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...
Just Arsenal on MSN
Barcelona will be a serious challenger to Arsenal for young Dutchman | OneFootball
Arsenal have a history of recruiting Dutch players, both in the past and in the present. Within the current squad, Jurrien ...
Pain represents the cardinal symptom of osteoarthritis, yet its intensity, quality, and impact vary dramatically among ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker ...
Discover Lulutox Detox Tea, a herbal blend designed to support digestion, detox balance, and daily wellness. Ingredients, ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果